AU2030288A - Anti-hyperlipemic agent - Google Patents

Anti-hyperlipemic agent

Info

Publication number
AU2030288A
AU2030288A AU20302/88A AU2030288A AU2030288A AU 2030288 A AU2030288 A AU 2030288A AU 20302/88 A AU20302/88 A AU 20302/88A AU 2030288 A AU2030288 A AU 2030288A AU 2030288 A AU2030288 A AU 2030288A
Authority
AU
Australia
Prior art keywords
hyperlipemic
agent
hyperlipemic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU20302/88A
Other versions
AU616423B2 (en
Inventor
Yoshio Hayashi
Osamu Nishikaze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAIICHI YAKUHIN SANGYO Co Ltd
Original Assignee
DAIICHI YAKUHIN SANGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAIICHI YAKUHIN SANGYO KK filed Critical DAIICHI YAKUHIN SANGYO KK
Publication of AU2030288A publication Critical patent/AU2030288A/en
Application granted granted Critical
Publication of AU616423B2 publication Critical patent/AU616423B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AU20302/88A 1987-08-07 1988-08-02 Anti-hyperlipemic agent Ceased AU616423B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62197735A JPS6440428A (en) 1987-08-07 1987-08-07 Antihyperlipemia
JP62-197735 1987-08-07

Publications (2)

Publication Number Publication Date
AU2030288A true AU2030288A (en) 1989-02-09
AU616423B2 AU616423B2 (en) 1991-10-31

Family

ID=16379469

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20302/88A Ceased AU616423B2 (en) 1987-08-07 1988-08-02 Anti-hyperlipemic agent

Country Status (7)

Country Link
JP (1) JPS6440428A (en)
KR (1) KR930001809B1 (en)
AU (1) AU616423B2 (en)
DE (1) DE3826297A1 (en)
FR (1) FR2619009B1 (en)
GB (1) GB2208473A (en)
IT (1) IT1226584B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736537A (en) 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
JPH10114789A (en) * 1996-10-14 1998-05-06 Kanebo Ltd Therapeutic agent for chronic fatigue syndrome
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
FR2803519B1 (en) * 2000-01-12 2002-03-22 Assist Publ Hopitaux De Paris ORAL USE OF DEHYDROEPIANDROSTERONE, ITS PRECURSORS AND DERIVATIVES FOR IMPROVING THE PAPYRACE OF THE SKIN
AU2002211563A1 (en) * 2000-10-06 2002-04-15 Aeson Therapeutics Inc. Compounds useful for treating hypertriglyceridemia
WO2023156803A1 (en) * 2022-02-17 2023-08-24 Debreceni Egyetem Dhea-derived steroids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE439586B (en) * 1975-09-05 1985-06-24 Kanebo Ltd SET TO PREPARE A STABLE PHARMACEUTICAL DRY PREPARATION OF AN ALKALIMETAL SALT OF DEHYDROEPIANDROSTERON SULPHATE
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
CA1314870C (en) * 1983-08-02 1993-03-23 Arthur G. Schwartz Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
US4666898A (en) * 1983-12-28 1987-05-19 Jackson Lab. Treatment of obesity, diabetes and other symptoms of hypercorticoidism using etiocholanolones

Also Published As

Publication number Publication date
KR890003386A (en) 1989-04-14
KR930001809B1 (en) 1993-03-13
IT8821626A0 (en) 1988-08-02
FR2619009A1 (en) 1989-02-10
IT1226584B (en) 1991-01-24
DE3826297A1 (en) 1989-02-16
FR2619009B1 (en) 1994-09-23
GB8818776D0 (en) 1988-09-07
GB2208473A (en) 1989-04-05
AU616423B2 (en) 1991-10-31
JPS6440428A (en) 1989-02-10

Similar Documents

Publication Publication Date Title
AU614965B2 (en) Thiadiazinones
AU2611588A (en) New phenylethanolamines
AU6101190A (en) Soilresisting agent
AU1407388A (en) Substituted di-t-butylphenols
EP0306805A3 (en) Fire-protecting agent
AU2222388A (en) Peptidylheterocycles
AU1381888A (en) Timeswitches
AU1301788A (en) Chemo-radio-immuno-conjugates
AU2142288A (en) New aluminium-magnesium-hydroxy-compounds
AU1764488A (en) Substituted 5-methylamino-1-arylpyrazoles
AU2669188A (en) Sweetening agent
AU7825387A (en) Light-screen agent
AU2665388A (en) 17-methylene-and 17-ethylidene-estratrienes
AU2784789A (en) Antisyncytial agent
AU1590788A (en) Leukaemia-inhibitory factor
AU2586688A (en) Moth- and beetle-proofing agents
AU1158888A (en) Scraper-spreader
AU2030288A (en) Anti-hyperlipemic agent
AU1366388A (en) Videosystem
AU2820289A (en) Bulking agent
AU2324888A (en) Anti-retroviral agent
AU2505988A (en) 3-aminopyrazolin-5-ones
AU2456688A (en) Dripulator
AU2698888A (en) Naphthothiazepinones
AU2021888A (en) Sulphonylaminoguanidinoazines

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired